Lyell Immunopharma, Inc.LYELNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank17
3Y CAGR-27.3%
5Y CAGR-0.8%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-27.3%/yr
Annual compound
5Y CAGR
-0.8%/yr
Recent deceleration
Percentile
P17
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $45.13M | -13.3% |
| 2024 | $52.04M | -22.3% |
| 2023 | $66.98M | -42.9% |
| 2022 | $117.31M | +31.7% |
| 2021 | $89.06M | +90.0% |
| 2020 | $46.88M | +19.7% |
| 2019 | $39.15M | - |